珊瑚在传统医药中的应用与可持续发展:化学成分、药理、毒理及临床研究综述
本综述总结近二十年传统医药中珊瑚的品种、化学成分、药理作用、毒理及临床研究。珊瑚用于藏、蒙、维、中医等56种复方,涉及34科99属,以软珊瑚科和肉芝软珊瑚属为主,化合物以萜类、甾体等为主,具抗肿瘤、抗炎等活性,但存在肝肾功能毒性及濒危保护问题。
要点
- 珊瑚用于56种传统复方,涉及34科99属,以软珊瑚科和肉芝软珊瑚属为主。
- 珊瑚化合物以萜类、甾体为主,具细胞毒、抗炎、抗菌、抗病毒等活性。
- 长期使用珊瑚制剂可致肝、肾、肺等器官剂量依赖性毒性,需关注。
核心结论
- 珊瑚在传统医药中应用广泛,但长期使用存在剂量依赖性器官毒性,且过度研究加剧其濒危状态,需从禁止、替代和合成角度保护。
研究设计与样本
- 综述近二十年传统医药中珊瑚的品种、化学成分、药理、毒理及临床研究。
- 涉及34科99属珊瑚的医学研究,以软珊瑚科和肉芝软珊瑚属为主要研究对象。
主要发现
- 珊瑚用于中医、藏医、蒙医、维医等56种复方。
- 化合物主要包括萜类(以倍半萜和二萜为主)、甾体、含氮化合物等。
- 生物活性包括细胞毒(抗肿瘤抗癌)、抗炎、镇痛、抗菌、抗病毒、免疫抑制、抗氧化及神经活性。
- 珊瑚毒性主要见于海洋观赏软珊瑚Zoanthidae科,主要毒性成分为岩沙海葵毒素。
- 珊瑚相关制剂配伍未见明显急性毒性,但长期使用仍可致肝、肾、肺等器官剂量依赖性毒性。
关键数值与推荐
- 临床单用珊瑚常作为骨科材料替代物治疗骨缺损、骨质增生等。
- 珊瑚复方制剂如二十五味珊瑚丸、珊瑚七十味丸广泛用于偏头痛、原发性头痛、癫痫、脑梗死、高血压等神经及心脑血管疾病。
临床怎么用
- 珊瑚单用可作为骨科材料替代物用于骨缺损、骨质增生等。
- 复方制剂如二十五味珊瑚丸、珊瑚七十味丸可用于偏头痛、癫痫、脑梗死、高血压等。
- 长期使用珊瑚制剂需监测肝、肾、肺等器官毒性,注意剂量依赖性。
局限性
- 珊瑚研究加剧其濒危状态,应完全禁止使用濒危物种并提供平等保护以助恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This review discusses the variety, chemical composition, pharmacological effects, toxicology, and clinical research of corals used in traditional medicine in the past two decades. At present, several types of medicinal coral resources are identified, which are used in 56 formulas such as traditional Chinese medicine, Tibetan medicine, Mongolian medicine, and Uyghur medicine. A total of 34 families and 99 genera of corals are involved in medical research, with the Alcyoniidae family and Sarcophyton genus being the main research objects. Based on the structural types of compounds and the families and genera of corals, this review summarizes the compounds primarily reported during the period, including terpenoids, steroids, nitrogen-containing compounds, and other terpenoids dominated by sesquiterpene and diterpenes. The biological activities of coral include cytotoxicity (antitumor and anticancer), anti-inflammatory, analgesic, antibacterial, antiviral, immunosuppressive, antioxidant, and neurological properties, and a detailed summary of the mechanisms underlying these activities or related targets is provided. Coral toxicity mostly occurs in the marine ornamental soft coral Zoanthidae family, with palytoxin as the main toxic compound. In addition, nonpeptide neurotoxins are extracted from aquatic corals. The compatibility of coral-related preparations did not show significant acute toxicity, but if used for a long time, it will still cause toxicity to the liver, kidneys, lungs, and other internal organs in a dose-dependent manner. In clinical applications, individual application of coral is often used as a substitute for orthopedic materials to treat diseases such as bone defects and bone hyperplasia. Second, coral is primarily available in the form of compound preparations, such as Ershiwuwei Shanhu pills and Shanhu Qishiwei pills, which are widely used in the treatment of neurological diseases such as migraine, primary headache, epilepsy, cerebral infarction, hypertension, and other cardiovascular and cerebrovascular diseases. It is undeniable that the effectiveness of coral research has exacerbated the endangered status of corals. Therefore, there should be no distinction between the advantages and disadvantages of listed endangered species, and it is imperative to completely prohibit their use and provide equal protection to help them recover to their normal numbers. This article can provide some reference for research on coral chemical composition, biological activity, chemical ecology, and the discovery of marine drug lead compounds. At the same time, it calls for people to protect endangered corals from the perspectives of prohibition, substitution, and synthesis.
引用
- Han M, Wang Z, Li Y, et al. The application and sustainable development of coral in traditional medicine and its chemical composition, pharmacology, toxicology, and clinical research. Front Pharmacol. 2024. PMID: 38235111. doi:10.3389/fphar.2023.1230608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。